Royalty Pharma (RPRX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Royalty Pharma, as the data feed reports them.

Analysts' mean target, 8 analysts
$72.00
4.8% above the price

The 8 analysts reported by the data feed have a mean price target for Royalty Pharma of $72.00, 4.8% above the $68.68 price (range $66.00–$78.00). 2.98% of the float was sold short as of Oct 30, 2026. Institutions hold 89.9% of the shares and insiders 6.5%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$72.00+4.8% vs price
Analysts
8
Short interest
2.98%of float, Oct 30, 2026
Short ratio
4.05 days
Institutions
89.9%
Insiders
6.50%
Beta
0.36

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

8 analysts covering Royalty Pharma, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $68.68.

Analysts' price targets for Royalty Pharma
Mean price target$72.004.8% above the price (+4.8%)
Median price target$74.007.7% above the price (+7.7%)
Highest target$78.0013.6% above the price (+13.6%)
Lowest target$66.003.9% below the price (−3.9%)
Analysts with a target8

Ratings this month · 9 analysts

Strong buy 2(22%)Buy 5(56%)Hold 2(22%)
Analysts' ratings of Royalty Pharma this month, by rating
RatingAnalystsShare
Strong buy222%
Buy556%
Hold222%
Sell00%
Strong sell00%

The feed averages these to 1.67 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “buy”.

Who owns Royalty Pharma

Ownership of Royalty Pharma
Held by institutions89.9%1,065 institutions; percent of shares outstanding
Held by institutions, of the float96.2%
Held by insiders6.50%percent of shares outstanding
Shares outstanding445.27M
Float417.1Mshares available to trade
Insiders' net purchases, six months−403.36K16 purchases (192.17K shares), 11 sales (595.53K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Royalty Pharma
Shares short13.08Mas of Oct 30, 2026
Percent of float2.98%shares short ÷ float
Percent of shares outstanding2.94%shares short ÷ shares outstanding
Short ratio (days to cover)4.05shares short ÷ average daily volume

Royalty Pharma short interest from FINRA, with its history

Trading figures

Trading figures for Royalty Pharma
Beta0.36movement against the market; 1 moves with it
52-week high$70.37
52-week low$37.31
Average volume, 3 months3.18Mshares a day
Average volume, 10 days3.72Mshares a day

Dates to know

Upcoming and recent dates for Royalty Pharma
Ex-dividend dateNov 13, 2026as the feed lists it
Dividend payment dateDec 10, 2026

Questions and answers

What is the analysts' price target for Royalty Pharma (RPRX)?

As reported by the data feed, the mean price target of the 8 analysts covering Royalty Pharma is $72.00, 4.8% above the latest price of $68.68. The highest target is $78.00 and the lowest $66.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Royalty Pharma stock?

Of the 9 ratings the data feed reports for the current month, 2 are strong buy, 5 buy, 2 hold, 0 sell and 0 strong sell.

How many Royalty Pharma shares are sold short?

As reported by the data feed, 13.08M shares were sold short, 2.98% of the float as of Oct 30, 2026. At the average daily volume that is 4.05 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Royalty Pharma stock?

As reported by the data feed, institutions hold 89.9% of the shares (1,065 institutions) and insiders 6.5%. There are 445.27M shares outstanding, of which 417.1M are in the float.

How much does Royalty Pharma stock move with the market?

Its beta, as reported by the data feed, is 0.36: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $37.31 and $70.37.

Cite this page

Funkfolio, “Royalty Pharma (RPRX) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/RPRX/statistics

Underlying data: Yahoo Finance.